首页> 外国专利> compound and use thereof, anticancer agent, combined preparation for simultaneous, separate or sequential administration in the treatment of cancer, pharmaceutical composition, radiation sensitizer and sensitizer for an anticancer agent

compound and use thereof, anticancer agent, combined preparation for simultaneous, separate or sequential administration in the treatment of cancer, pharmaceutical composition, radiation sensitizer and sensitizer for an anticancer agent

机译:化合物及其用途,抗癌剂,用于同时,分开或依次给药的组合制剂用于治疗癌症,药物组合物,放射线致敏剂和抗癌剂敏化剂

摘要

B COMPOSITE AND USE OF THE SAME, ANTICHANGEOUS AGENT, COMBINED PREPARATION FOR SIMULTANEOUS, SEPARATE, OR SEQUENTIAL ADMINISTRATION IN CANCER, PHARMACEUTICAL COMPOSITION, RADIATION SENSITIZER A GENERAL SENSITIVE formula (I): wherein A1 is selected from the following formula (aa1); R4 is a lower alkenyl group or lower alkynyl group; R2 is a phenyl, pyridyl or thienyl group; R 5 and R 6 are a hydrogen atom, a lower alkenyl group, or a lower alkyl hydroxy group, etc. The compounds of the invention have excellent weel kinase inhibitory effect and are therefore useful in the medical field, especially in the treatment of various cancers.
机译:相同,不同的试剂,同时,分别或依次进行的癌症,药物成分,辐射敏化剂的共同制备的组合物和用途:通用的化学式(I):其中A1选自以下的化学式(aa1) ; R4是低级烯基或低级炔基; R2是苯基,吡啶基或噻吩基; R 5和R 6是氢原子,低级烯基或低级烷基羟基等。本发明的化合物具有优异的Weel激酶抑制作用,因此可用于医学领域,特别是在治疗各种疾病中。癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号